IMUN

Immune Therapeutics, Inc. [IMUN] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

IMUN Stock Summary

In the News

IMUN Financial details

Company Rating
-
Market Cap
7.78M
Income
-1.6M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
29 Jun 2020
P/E
-1.34
Forward P/E
-
PEG
0.13
P/S
-
P/B
-2.5
P/C
-
P/FCF
-12.95
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.02
EPS next Y
-
EPS next Q
-
EPS this Y
-142.11%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-61.55%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-22.95%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-760%
ROE
210%
ROC
0.49%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.06675-1.3
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
13.34K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.255789
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

Something similar

Top by Market Cap
LLY
LLY.SW
META
AAPL
3V64.DE
Same Sector
CSU
OCX
002620.KS
TIL
6127.HK
Check Those
BUFD
005385.KS
600587.SS
002986.SZ
KAKEL.ST
Similar Market Cap
FNTS.PA
FPA
EMBH
PHARM.ST
CYXO.ST

Company Profile

Healthcare Biotechnology

Immune Therapeutics, Inc. does not have significant operations. The company was formerly known as TNI BioTech, Inc. and changed its name to Immune Therapeutics, Inc. in October 2014. Immune Therapeutics, Inc. is headquartered in Orlando, Florida.